Fresenius SE & Co KGaA operates within the Kidney dialysis centers sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius SE & Co KGaA with three other
health care providers in Europe:
Ramsay Generale De Sante
sales of 2.23 billion Euro [US$2.39 billion]
of which 82%
Fresenius Medical Care AG & Co. KGaA
(16.23 billion Euro [US$17.43 billion]
of which 72%
was North America), and
based in France
(2.84 billion Euro [US$3.05 billion]
During the year ended December of 2016, sales at
Fresenius SE & Co KGaA were 29.47 billion Euro (US$31.66 billion).
increase of 5.3%
versus 2015, when the company's sales were 28.00 billion Euro.
This was the fifth consecutive year of sales increases at Fresenius SE & Co KGaA
(and since 2011, sales have increased a total of 78%).
Sales of Fresenius Medical Care saw an increase
7.3% in 2016, from
15.06 billion Euro to 16.16 billion Euro.
Not all segments of Fresenius SE & Co KGaA experienced an increase in sales in 2016:
sales of Corporate/other fell 33.3% to 4.00 million Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).